🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Interstitial Lung Disease With Systemic Sclerosis

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD19- BCMA CAR-T cells Western Sweden Systemic Sclerosis Project NCT07345052n/a1 site📍 Gothenburg Sahlgrenska University Hospital · Tests: No Intervention: Observational Cohort A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease NCT06189495Phase 24 sites📍 Beijing📍 Wuhan📍 Jinan Changchun GeneScience Pharmaceutical Co., Ltd. · Tests: GenSci048, GenSci048 placebo A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease NCT05878717Phase 2, Phase 3134 sites📍 Phoenix📍 Scottsdale📍 Scottsdale GlaxoSmithKline · Tests: Belimumab, Placebo Registry of Autoimmune Interstitial Lung Disease NCT05365009n/a1 site📍 Buenos Aires EPIMAR registry · Tests: Multidisciplinary aproach Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease NCT06297096Phase 31 site📍 Warsaw National Institute of Geriatrics, Rheumatology and Rehabili… · Tests: Tocilizumab, Nintedanib, Standard therapy Platform Clinical Study for Conquering Scleroderma NCT06195072Phase 234 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Scleroderma Research Foundation, Inc. · Tests: Amlitelimab, BI 1015550 (Nerandomilast), Placebo RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis NCT06328777Phase 2, Phase 310 sites📍 New Haven📍 Jacksonville📍 Chicago Cabaletta Bio · Tests: CABA-201, CABA-201 Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis NCT06549231Phase 31 site📍 Tours University Hospital, Tours · Tests: Rituximab, Placebo Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD) NCT05892614Phase 215 sites📍 Los Angeles📍 San Diego📍 Miami aTyr Pharma, Inc. · Tests: efzofitimod 450 mg, efzofitimod 270 mg, Placebo Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease NCT07723872n/a1 site📍 Granollers Hospital de Granollers · Tests: Dual-site pulse oximetry (finger and earlobe) Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases NCT06732674NA1 site📍 Oslo Oslo University Hospital · Tests: A home monitoring strategy with event driven management A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis NCT07047690Phase 23 sites📍 Ann Arbor📍 Arlington📍 Sankt Gallen Galderma R&D · Tests: Nemolizumab, Placebo Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases NCT07087912Phase 42 sites📍 São Paulo📍 São Paulo University of Sao Paulo General Hospital · Tests: Dengue 1,2,3,4 (attenuated) vaccine A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE) NCT06716606Phase 341 sites📍 Los Angeles📍 New York📍 Philadelphia GlaxoSmithKline · Tests: Belimumab Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease NCT05785065Phase 23 sites📍 Montreal📍 Montreal📍 Québec Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Mycophenolate Mofetil, Placebo Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis NCT03630211Phase 23 sites📍 Pittsburgh📍 Pittsburgh📍 Pittsburgh Paul Szabolcs · Tests: Cyclophosphamide, Mesna, Rituximab, Alemtuzumab, Thiotepa Connective Tissue Diseases and Lung Manifestations NCT04095351n/a1 site📍 Innsbruck Medical University Innsbruck · Tests: Pulmonary function test, Imaging, Blood sampling
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy